CRISPR Therapeutics AG Quarterly Current Ratio in % from Q2 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
CRISPR Therapeutics AG quarterly Current Ratio history and growth rate from Q2 2017 to Q3 2024.
  • CRISPR Therapeutics AG Current Ratio for the quarter ending September 30, 2024 was 1.79K %, a 24.3% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.79K +350 +24.3% Sep 30, 2024
Q2 2024 1.67K +301 +22% Jun 30, 2024
Q1 2024 1.62K +173 +11.9% Mar 31, 2024
Q4 2023 1.49K -124 -7.71% Dec 31, 2023
Q3 2023 1.44K -287 -16.6% Sep 30, 2023
Q2 2023 1.37K -699 -33.8% Jun 30, 2023
Q1 2023 1.45K -837 -36.6% Mar 31, 2023
Q4 2022 1.61K -740 -31.5% Dec 31, 2022
Q3 2022 1.73K -598 -25.7% Sep 30, 2022
Q2 2022 2.07K -23.2 -1.11% Jun 30, 2022
Q1 2022 2.28K +527 +30% Mar 31, 2022
Q4 2021 2.35K +729 +44.9% Dec 31, 2021
Q3 2021 2.33K +749 +47.5% Sep 30, 2021
Q2 2021 2.09K +761 +57.2% Jun 30, 2021
Q1 2021 1.76K +406 +30% Mar 31, 2021
Q4 2020 1.62K +333 +25.8% Dec 31, 2020
Q3 2020 1.58K +371 +30.8% Sep 30, 2020
Q2 2020 1.33K -214 -13.9% Jun 30, 2020
Q1 2020 1.35K -279 -17.1% Mar 31, 2020
Q4 2019 1.29K -480 -27.1% Dec 31, 2019
Q3 2019 1.21K -585 -32.7% Sep 30, 2019
Q2 2019 1.54K -453 -22.7% Jun 30, 2019
Q1 2019 1.63K -374 -18.7% Mar 31, 2019
Q4 2018 1.77K -56.6 -3.1% Dec 31, 2018
Q3 2018 1.79K +61.2 +3.54% Sep 30, 2018
Q2 2018 2K +1.15K +135% Jun 30, 2018
Q1 2018 2.01K Mar 31, 2018
Q4 2017 1.83K Dec 31, 2017
Q3 2017 1.73K Sep 30, 2017
Q2 2017 850 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.